| 1 | North American Physician Practice Patterns in the Management of Anticoagulation in Pregnancy. (Cohen AJ, Boggio L, Billett HH, DeSancho MT, Gaddh M, Kouides P, Lim M, Nyak L, Rajan S, Rosovsky R, Streiff M, Wang TF, Baumann Kreuziger L) J Womens Health (Larchmt) 2021 06;30(6):829-836 1 Citation |
| 1 | Biallelic variants in PROZ as a cause of hypercoagulability and livedo racemosa. (Pinto E Vairo F, Kroc SA, Bertsch NL, Sigafoos AN, Lee HB, Dsouza NR, Clark KJ, Pichurin PN, Zimmermann MT, Klee EW) Thromb Res 2020 11;195:187-189 1 Citation |
| 3 | Blood transfusions increase the risk of venous thromboembolism following ventral hernia repair. (Helm JH, Helm MC, Kindel TL, Gould JC, Higgins RM) Hernia 2019 Dec;23(6):1149-1154 7 Citations |
| 1 | Diagnostic Testing Approaches for Activated Protein C Resistance and Factor V Leiden: A Comparison of Institutional and National Provider Practices. (Perez Botero J, Majerus JA, Strege AK, Johnson RD, Chen D, Pruthi RK) Am J Clin Pathol 2017 Jun 01;147(6):604-610 5 Citations |
| 1 | Combined hormonal contraception and the risk of venous thromboembolism: a guideline. (Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine) Fertil Steril 2017 01;107(1):43-51 63 Citations |
| 1 | Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study. (Perez Botero J, Ormsby WD, Ashrani AA, McBane RD 2nd, Wysokinski WE, Patnaik MM, Lewis BR, Grill DE, Pruthi RK, Heit JA) Eur J Intern Med 2016 May;30:77-81 5 Citations |
| 1 | Inherited and secondary thrombophilia. (Cohoon KP, Heit JA) Circulation 2014 Jan 14;129(2):254-7 15 Citations |
| 1 | Risk Factors and Treatment Strategies in Patients With Retinal Vascular Occlusions. (Chapin J, Carlson K, Christos PJ, DeSancho MT) Clin Appl Thromb Hemost 2015 Oct;21(7):672-7 11 Citations |
| 1 | Loss of expression of neutrophil proteinase-3: a factor contributing to thrombotic risk in paroxysmal nocturnal hemoglobinuria. (Jankowska AM, Szpurka H, Calabro M, Mohan S, Schade AE, Clemente M, Silverstein RL, Maciejewski JP) Haematologica 2011 Jul;96(7):954-62 12 Citations |
| 1 | Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability. (Seehaus S, Shahzad K, Kashif M, Vinnikov IA, Schiller M, Wang H, Madhusudhan T, Eckstein V, Bierhaus A, Bea F, Blessing E, Weiler H, Frommhold D, Nawroth PP, Isermann B) Circulation 2009 Sep 01;120(9):774-84 53 Citations |
| 1 | Thrombophilia and fetal loss: Lessons from gene targeting in mice. (Sood R) Thromb Res 2009;123 Suppl 2:S79-84 7 Citations |
| 2 | Maternal Par4 and platelets contribute to defective placenta formation in mouse embryos lacking thrombomodulin. (Sood R, Sholl L, Isermann B, Zogg M, Coughlin SR, Weiler H) Blood 2008 Aug 01;112(3):585-91 28 Citations |
| 2 | Combined tissue factor pathway inhibitor and thrombomodulin deficiency produces an augmented hypercoagulable state with tissue-specific fibrin deposition. (Maroney SA, Cooley BC, Sood R, Weiler H, Mast AE) J Thromb Haemost 2008 Jan;6(1):111-7 28 Citations |
| 3 | Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells. (Sood R, Kalloway S, Mast AE, Hillard CJ, Weiler H) Blood 2006 Apr 15;107(8):3173-80 73 Citations |
| 2 | Thrombophilia and pregnancy failure: feto-maternal interactions in the vascular bed of the placenta. (Sood R, Kalloway S, Mast AE, Weiler H) Thromb Res 2005 Feb;115 Suppl 1:92-4 2 Citations |
| 1 | A prothrombotic phenotype in the Copenhagen rat strain. (Cooley BC, Chen CY, Friedman KD, Datta Y) Thromb Res 2005;115(1-2):153-7 1 Citation |
| 2 | Embryogenesis and gene targeting of coagulation factors in mice. (Sood R, Weiler H) Best Pract Res Clin Haematol 2003 Jun;16(2):169-81 4 Citations |
| 1 | Mouse models in coagulation. (Hogan KA, Weiler H, Lord ST) Thromb Haemost 2002 Apr;87(4):563-74 42 Citations |
| 1 | Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity. (Raife TJ, Lentz SR, Atkinson BS, Vesely SK, Hessner MJ) Blood 2002 Jan 15;99(2):437-42 49 Citations |
| 1 | Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis. (Isermann B, Hendrickson SB, Zogg M, Wing M, Cummiskey M, Kisanuki YY, Yanagisawa M, Weiler H) J Clin Invest 2001 Aug;108(4):537-46 106 Citations |
| 1 | Terminal ileum resection is associated with higher plasma homocysteine levels in Crohn's disease. (Vasilopoulos S, Saiean K, Emmons J, Berger WL, Abu-Hajir M, Seetharam B, Binion DG) J Clin Gastroenterol 2001 Aug;33(2):132-6 28 Citations |
© 2022 Clinical & Translational Science Institute